Literature DB >> 321502

Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols.

S L Spector, M Garza Gomez.   

Abstract

Albuterol aerosol was an effective bronchodilator as reflected by indices of pulmonary function obtained from spirometry and flow volume curves; Compared with isoproterenol, there were minimal side effects even at the highest doses, and bronchodilation lasted significantly longer. In addition albuterol was successfully used by a patient with idiopathic hypertrophic subaortic stenosis who was unable to tolerate isoproterenol, as well as by some patients with idiosyncratic responses to isoproterenol; A few patients appeared to derive little benefit from either albuterol or isoproterenol.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321502     DOI: 10.1016/0091-6749(77)90048-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  Comparison of hypokalaemic, electrocardiographic and haemodynamic responses to inhaled isoprenaline and salbutamol in young and elderly subjects.

Authors:  B J Lipworth; B F Tregaskis; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Current Bronchodilator Responsiveness Criteria Underestimate Asthma in Older Adults.

Authors:  Rodrigo S Cavallazzi; Barbara J Polivka; Bryan L Beatty; Demetra E Antimisiaris; Rangaraj K Gopalraj; Rachel A Vickers-Smith; Rodney J Folz
Journal:  Respir Care       Date:  2020-02-18       Impact factor: 2.258

3.  Aerosol and air filter therapy.

Authors:  H Chai; S L Spector
Journal:  Bull N Y Acad Med       Date:  1981-09

4.  Beta-adrenoceptor responses to high doses of inhaled salbutamol in patients with bronchial asthma.

Authors:  B J Lipworth; R A Clark; D P Dhillon; R A Brown; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

Review 5.  Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

Authors:  Shelley R Salpeter
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.